Capula Management’s Medtronic MDT Stock Holding History

Capula Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217K	Buy	2,500 +800	+47%	+$76.6K	﹤0.01%	721
2025 Q4	$163K	Sell	1,700 -400	-19%	-$38.9K	﹤0.01%	633
2025 Q3	$200K	Buy	2,100 +700	+50%	+$64.3K	﹤0.01%	612
2025 Q2	$122K	Buy	+1,400	New	+$119K	﹤0.01%	473
2024 Q4	–	Sell	-2,200	Closed	-$198K	–	511
2024 Q3	$198K	Buy	+2,200	New	+$185K	﹤0.01%	378
2023 Q3	–	Sell	-29,300	Closed	-$2.58M	–	604
2023 Q2	$2.58M	Sell	29,300 -36,000	-55%	-$3.1M	0.06%	128
2023 Q1	$5.26M	Sell	65,300 -51,400	-44%	-$4.19M	0.06%	233
2022 Q4	$9.07M	Sell	116,700 -312,000	-73%	-$25.3M	0.12%	193
2022 Q3	$34.6M	Buy	428,700 +320,700	+297%	+$28.8M	0.47%	45
2022 Q2	$9.69M	Buy	+108,000	New	+$10.9M	0.17%	147
2020 Q3	–	Sell	-10,500	Closed	-$963K	–	255
2020 Q2	$963K	Sell	10,500 -36,400	-78%	-$3.49M	0.03%	251
2020 Q1	$4.23M	Buy	+46,900	New	+$4.99M	0.15%	172

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's MDT Position: Q1 2026 in Review

Capula Management increased its Medtronic (MDT) stake by 170% in Q1 2026, buying an estimated $422K and bringing the position to 6,991 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Capula Management first reported a position in MDT in Q1 2020 and has held it in 14 quarters since. The position peaked at $7.14M in Q3 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Capula Management held 6,991 shares of Medtronic worth $606K as of Q1 2026.
Capula Management bought 4,405 Medtronic shares in Q1 2026, an estimated $422K.
Medtronic made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #469 holding.
Capula Management first reported a position in Medtronic in Q1 2020 and has held it in 14 quarters since.
Capula Management's Medtronic position peaked at $7.14M in Q3 2022.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.